PR Newswire: news distribution, targeting and monitoring
2014

Biodel to Present at JMP Securities Healthcare Conference

Share with Twitter Share with LinkedIn

DANBURY, Conn., July 10, 2012 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) announced today that management will be presenting an overview of the Company's technologies, development programs, and outlook on Friday, July 13, 2012 at 11:30 a.m. EDT at the Seventh Annual JMP Securities Healthcare Conference (New York, July 12 - 13).

A live and archived webcast of the presentation will be accessible by visiting the Biodel website at www.biodel.com under "Webcasts" in the "News & Events" section.

About Biodel Inc.

Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes that may be safer, more effective and more convenient for patients. We develop our product candidates by applying our proprietary formulation technologies to existing drugs in order to improve their therapeutic profiles.

BIOD-G
Contact: Seth D. Lewis, +1-646-378-2952
News Provided by Acquire Media

SOURCE Biodel Inc.



RELATED LINKS
http://www.biodel.com

Featured Video

Journalists and Bloggers

Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.

View and download archived video content distributed by MultiVu on The Digital Center.

Share with Twitter Share with LinkedIn
 

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

 
 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

 
 

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.

 

Online Member Center

Not a Member?
Click Here to Join
Login
Search News Releases
Advanced Search
Search
  1. PR Newswire Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
  5. Send a News Release